Mantara Wins Prestigious PING Innovation Award 2023

We are delighted to share the news that we have won the 2023 PING Innovation Award for our transformative pharmacogenomics (PGx) saliva-based test, another major step in personalised medicine. This award, organised by national law firm VWV, recognises the most innovative ideas, products, services or processes in the Pharmaceuticals and Life Sciences sector. 

Dr Mark Hudson-Peacock and Charles Gloor receiving the PING Innovation Award.

Our PGx test is a simple and non-invasive saliva test that analyses a person's genetic profile and predicts how they will respond to various medications. The test helps doctors prescribe the right drug, at the right dose, first time for each patient, therefore reducing the risk of adverse reactions and improving treatment outcomes. 

We are honoured and thrilled to receive this prestigious award. It is testament to our team's hard work and dedication to developing innovative solutions that improve patient care and quality of life. 

Thank you to VWV, the organisers of the event, and the selection committee for recognising our achievement and potential. 

We would also like to thank Paul Gershlick, Head of Pharma & Life Sciences at law firm VWV and Chair of PING, and Paul Witcombe, Life Sciences and Advanced Manufacturing Lead at the Hertfordshire Local Enterprise Partnership, for presenting us the award at the PING Conference 2023. 

Also, we would like to congratulate the runners up, Cygenica & Takeda for their outstanding submissions. 

We are proud to be part of such a vibrant and dynamic sector that is driving innovation and excellence in healthcare. 

The Mantara Team at the VWV awards ceremony.